BIA
ABBV icon

Biondo Investment Advisors’s AbbVie ABBV Stock Holding History

Biondo Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.6M Buy
76,262
+14
+0% +$3.11K 2.13% 13
2025
Q4 		$17.4M Sell
76,248
-2,336
-3% -$532K 2.11% 11
2025
Q3 		$18.2M Sell
78,584
-65
-0.1% -$13.2K 2.28% 10
2025
Q2 		$14.6M Buy
78,649
+585
+0.7% +$109K 1.92% 13
2025
Q1 		$16.4M Buy
78,064
+205
+0.3% +$39.9K 2.32% 11
2024
Q4 		$13.8M Buy
77,859
+1
+0% +$184 1.91% 15
2024
Q3 		$15.4M Buy
77,858
+302
+0.4% +$56.4K 2.11% 14
2024
Q2 		$13.3M Buy
77,556
+1,488
+2% +$246K 1.97% 14
2024
Q1 		$13.9M Sell
76,068
-259
-0.3% -$44.6K 2.14% 13
2023
Q4 		$11.8M Sell
76,327
-1,095
-1% -$160K 2.01% 13
2023
Q3 		$11.5M Buy
77,422
+2,086
+3% +$306K 2.17% 13
2023
Q2 		$10.2M Buy
75,336
+595
+0.8% +$87.3K 1.88% 18
2023
Q1 		$11.9M Buy
74,741
+476
+0.6% +$72.8K 2.41% 11
2022
Q4 		$12M Sell
74,265
-1,297
-2% -$199K 2.67% 8
2022
Q3 		$10.1M Buy
75,562
+340
+0.5% +$48.8K 2.34% 11
2022
Q2 		$11.5M Buy
75,222
+2,027
+3% +$310K 2.54% 10
2022
Q1 		$11.9M Buy
73,195
+1,098
+2% +$159K 2.09% 15
2021
Q4 		$9.76M Buy
72,097
+2,233
+3% +$264K 1.63% 19
2021
Q3 		$7.54M Buy
69,864
+1,991
+3% +$228K 1.29% 24
2021
Q2 		$7.64M Buy
67,873
+2,750
+4% +$310K 1.31% 22
2021
Q1 		$7.05M Sell
65,123
-104
-0.2% -$11.1K 1.4% 21
2020
Q4 		$6.99M Buy
65,227
+870
+1% +$83.6K 1.34% 22
2020
Q3 		$5.64M Buy
64,357
+1,958
+3% +$184K 1.22% 29
2020
Q2 		$6.13M Buy
62,399
+1,015
+2% +$89.4K 1.55% 17
2020
Q1 		$4.68M Buy
61,384
+2,030
+3% +$173K 1.55% 24
2019
Q4 		$5.25M Sell
59,354
-660
-1% -$54.8K 1.21% 28
2019
Q3 		$4.54M Sell
60,014
-907
-1% -$62.2K 1.16% 31
2019
Q2 		$4.43M Sell
60,921
-3,425
-5% -$269K 1.05% 34
2019
Q1 		$5.19M Sell
64,346
-3,224
-5% -$264K 1.3% 26
2018
Q4 		$6.23M Sell
67,570
-1,060
-2% -$93.2K 1.88% 15
2018
Q3 		$6.49M Buy
68,630
+769
+1% +$72.9K 1.54% 17
2018
Q2 		$6.29M Buy
67,861
+4,610
+7% +$450K 1.59% 18
2018
Q1 		$5.99M Sell
63,251
-30
-0% -$3.3K 1.56% 20
2017
Q4 		$6.12M Buy
63,281
+285
+0.5% +$26.9K 1.55% 20
2017
Q3 		$5.6M Buy
62,996
+230
+0.4% +$17.5K 1.54% 21
2017
Q2 		$4.55M Buy
62,766
+3,654
+6% +$246K 1.32% 23
2017
Q1 		$3.66M Sell
59,112
-1,060
-2% -$66.6K 1.31% 28
2016
Q4 		$3.77M Buy
60,172
+687
+1% +$41.9K 1.25% 25
2016
Q3 		$3.75M Buy
59,485
+27
+0% +$1.75K 1.27% 28
2016
Q2 		$3.68M Buy
59,458
+24,290
+69% +$1.48M 1.31% 28
2016
Q1 		$2.01M Sell
35,168
-12,212
-26% -$681K 0.76% 41
2015
Q4 		$2.81M Buy
47,380
+2,555
+6% +$147K 0.93% 34
2015
Q3 		$2.44M Buy
+44,825
New +$2.92M 0.81% 36
2014
Q1 		– Sell
-24,962
Closed -$1.32M – 93
2013
Q4 		$1.32M Buy
24,962
+5,742
+30% +$282K 0.45% 47
2013
Q3 		$860K Buy
19,220
+5,300
+38% +$235K 0.33% 57
2013
Q2 		$575K Buy
+13,920
New +$609K 0.25% 67

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Biondo Investment Advisors's ABBV Position: Q1 2026 in Review

Biondo Investment Advisors increased its AbbVie (ABBV) stake by 0.02% in Q1 2026, buying an estimated $3.11K and bringing the position to 76,262 shares worth $16.6M. The position accounts for 2.13% of the portfolio, ranked #13.

Biondo Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. The position peaked at $18.2M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Biondo Investment Advisors held 76,262 shares of AbbVie worth $16.6M as of Q1 2026.
  • Biondo Investment Advisors bought 14 AbbVie shares in Q1 2026, an estimated $3.11K.
  • AbbVie made up 2.13% of Biondo Investment Advisors's portfolio in Q1 2026, its #13 holding.
  • Biondo Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
  • Biondo Investment Advisors's AbbVie position peaked at $18.2M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.